| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 39.61× | 39.61× | 42.71× | 47.15× | 53.07× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.19× | 0.19× | 0.19× | 0.19× | 0.18× | ||
| −2.40× | −2.40× | −2.37× | −0.58× | −2.04× | ||
| −1.08× | −1.08× | −1.20× | −0.36× | −1.11× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 53.07 | 47.15 | 42.71 | 39.61 | 39.61 | |
| Asset Turnover | 0.18 | 0.19 | 0.19 | 0.19 | 0.19 | |
| Cash Conversion (CFO/Net Income) | -2.04 | -0.58 | -2.37 | -2.40 | -2.40 | |
| CFO/EBITDA | -1.11 | -0.36 | -1.20 | -1.08 | -1.08 |